Trademark: 97505505
Status Date
Monday, March 4, 2024
Filing Date
Friday, July 15, 2022
Published for Opposition
Tuesday, June 6, 2023
Abandoned Date
Monday, March 4, 2024
40 Custom manufacturing of gene therapies; custom manufacturing of pharmaceuticals
5 Therapeutic pharmaceuticals for the treatment of liver disease and disorders; pharmaceuticals for the treatment of genetic disorders; Biological tissue, namely, human cells for use in cellular healing therapies
44 Regenerative medicine services; treatment of liver disease; treatment of genetic disorders
42 Scientific research and development; medical research; biotechnology research; medical and scientific research, namely, conducting clinical, preclinical, and nonclinical trials for others; providing medical and scientific research information in the field of clinical, preclinical, and nonclinical trials; medical and scientific research, namely, testing of gene therapies; pharmaceutical drug development services; cell research and development of cell therapies; clinical testing of cell therapies; research and development of gene therapies
Mar 4, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2024
Abandonment - No Use Statement Filed
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 3, 2023
Approved For Pub - Principal Register
May 1, 2023
Examiner's Amendment Entered
May 1, 2023
Notification Of Examiners Amendment E-Mailed
May 1, 2023
Examiners Amendment E-Mailed
May 1, 2023
Examiners Amendment -Written
May 1, 2023
Assigned To Examiner
Aug 4, 2022
New Application Office Supplied Data Entered
Jul 19, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
